Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
29 09 2021
Historique:
received: 10 03 2021
accepted: 23 08 2021
entrez: 29 9 2021
pubmed: 30 9 2021
medline: 9 11 2021
Statut: epublish

Résumé

In post-industrial settings, apolipoprotein Genes contain the instructions needed for a cell to make molecules called proteins, which perform various roles in the body. Different variants of a gene can affect how the protein works, and in some cases, can increase a person’s risk to develop certain diseases. For example, people who carry a version of the apolipoprotein E gene called APOE4 have a greater risk of developing Alzheimer’s disease or heart disease. Individuals with two copies of this genetic variant have a 45% higher risk of heart disease and 12 times higher risk of Alzheimer’s disease. Studies in industrialized countries suggest this increased risk may be the result of higher cholesterol and inflammation in people with APOE4. But if APOE4 is harmful, why does it continue to be so common worldwide? One potential explanation is that APOE4, which has been around since before modern humans, may be beneficial in some contexts. Cholesterol is essential for many vital tasks in the body. In physically demanding environments where parasitic infections are common – conditions similar to those experienced by early humans – APOE4 might be beneficial. Under those circumstances, having more cholesterol might help fuel metabolic activities, fight infections, or reduce inflammation caused by infections. Garcia et al. investigated the link between the APOE4 genetic variant, cholesterol and inflammation in 1,266 Indigenous Tsimane people from 80 villages in Bolivia. Tsimane people live an active lifestyle foraging and farming for food. Parasite infections are a common problem in their communities, but obesity rates are very low. Garcia et al. found that Tsimane people with at least one copy of the APOE4 have lower levels of inflammation and higher levels of cholesterol than those who have two copies of the APOE3 version of the gene. Very lean people with APOE4 had especially high levels of the so called “bad” low density lipoprotein (LDL) cholesterol compared to people with APOE3 only. However, in this situation, storing a little extra cholesterol may not be so bad. The findings contradict other studies that have linked obesity to higher LDL levels and APOE4 to higher levels of inflammation. For the majority of human history, humans lived in more physically strenuous and calorically restrictive environments, with less access to clean water. Garcia et al. suggest that the harmful effects of APOE4 seen in studies in more industrialized societies – where people tend to be more sedentary and have less exposure to pathogens – may reflect a mismatch between a person’s environment and their genes. More studies that capture the diversity of environmental conditions under which people live will help clarify the role of APOE4 health and disease.

Autres résumés

Type: plain-language-summary (eng)
Genes contain the instructions needed for a cell to make molecules called proteins, which perform various roles in the body. Different variants of a gene can affect how the protein works, and in some cases, can increase a person’s risk to develop certain diseases. For example, people who carry a version of the apolipoprotein E gene called APOE4 have a greater risk of developing Alzheimer’s disease or heart disease. Individuals with two copies of this genetic variant have a 45% higher risk of heart disease and 12 times higher risk of Alzheimer’s disease. Studies in industrialized countries suggest this increased risk may be the result of higher cholesterol and inflammation in people with APOE4. But if APOE4 is harmful, why does it continue to be so common worldwide? One potential explanation is that APOE4, which has been around since before modern humans, may be beneficial in some contexts. Cholesterol is essential for many vital tasks in the body. In physically demanding environments where parasitic infections are common – conditions similar to those experienced by early humans – APOE4 might be beneficial. Under those circumstances, having more cholesterol might help fuel metabolic activities, fight infections, or reduce inflammation caused by infections. Garcia et al. investigated the link between the APOE4 genetic variant, cholesterol and inflammation in 1,266 Indigenous Tsimane people from 80 villages in Bolivia. Tsimane people live an active lifestyle foraging and farming for food. Parasite infections are a common problem in their communities, but obesity rates are very low. Garcia et al. found that Tsimane people with at least one copy of the APOE4 have lower levels of inflammation and higher levels of cholesterol than those who have two copies of the APOE3 version of the gene. Very lean people with APOE4 had especially high levels of the so called “bad” low density lipoprotein (LDL) cholesterol compared to people with APOE3 only. However, in this situation, storing a little extra cholesterol may not be so bad. The findings contradict other studies that have linked obesity to higher LDL levels and APOE4 to higher levels of inflammation. For the majority of human history, humans lived in more physically strenuous and calorically restrictive environments, with less access to clean water. Garcia et al. suggest that the harmful effects of APOE4 seen in studies in more industrialized societies – where people tend to be more sedentary and have less exposure to pathogens – may reflect a mismatch between a person’s environment and their genes. More studies that capture the diversity of environmental conditions under which people live will help clarify the role of APOE4 health and disease.

Identifiants

pubmed: 34586066
doi: 10.7554/eLife.68231
pii: 68231
pmc: PMC8480980
doi:
pii:

Substances chimiques

Apolipoprotein E4 0
Biomarkers 0
Lipids 0

Banques de données

Dryad
['10.5061/dryad.pg4f4qrpt']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R01 AG024119
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG024119
Pays : United States

Informations de copyright

© 2021, Garcia et al.

Déclaration de conflit d'intérêts

AG, CF, MG, TK, DE, DC, MC, KB, BB, HA, GT, JS, MG, HK, BT No competing interests declared

Références

Microbiol Immunol. 2010 Apr;54(4):246-53
pubmed: 20377753
Front Immunol. 2020 Apr 30;11:754
pubmed: 32425941
Ann Hum Genet. 1999 Jul;63(Pt 4):301-10
pubmed: 10738542
Am J Phys Anthropol. 2020 Nov;173(3):463-479
pubmed: 33460061
Genes (Basel). 2019 Mar 15;10(3):
pubmed: 30884759
J Gerontol A Biol Sci Med Sci. 2021 Jan 18;76(2):e1-e3
pubmed: 32777042
ISRN Obes. 2013 Jan 17;2013:142097
pubmed: 24634792
Front Aging Neurosci. 2020 Jun 10;12:150
pubmed: 32587511
Evol Med Public Health. 2016 Sep 25;2016(1):338-357
pubmed: 27666719
Am J Hum Biol. 2010 Jul-Aug;22(4):546-56
pubmed: 20309883
Ann Hum Biol. 2005 May-Jun;32(3):351-65
pubmed: 16099779
J Immunol Methods. 2010 Oct 31;362(1-2):112-20
pubmed: 20850446
Pediatr Res. 2005 Feb;57(2):310-6
pubmed: 15611352
Nat Rev Immunol. 2006 Jul;6(7):508-19
pubmed: 16778830
Am J Clin Nutr. 2018 Dec 1;108(6):1183-1195
pubmed: 30383188
Int J Geriatr Psychiatry. 2010 Apr;25(4):338-44
pubmed: 19618379
PLoS One. 2013;8(1):e55679
pubmed: 23383262
Lancet. 2017 Nov 4;390(10107):2034-2035
pubmed: 29115238
Lancet. 2017 Apr 29;389(10080):1730-1739
pubmed: 28320601
Braz J Med Biol Res. 2010 Mar;43(3):249-56
pubmed: 20401432
Ann Hum Biol. 2016 Jul;43(4):382-96
pubmed: 27174705
PLoS One. 2012;7(7):e41525
pubmed: 22844488
Neuropathol Appl Neurobiol. 2019 Jun;45(4):327-346
pubmed: 30394574
Triangle. 1957 Mar;3(1):20-5
pubmed: 13455726
J Allergy Clin Immunol. 2016 Sep;138(3):666-675
pubmed: 27476889
J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):196-9
pubmed: 18314457
Am J Hum Biol. 2010 Nov-Dec;22(6):731-40
pubmed: 20721985
Science. 2015 Nov 20;350(6263):970-2
pubmed: 26586763
J Alzheimers Dis. 2019;68(3):885-923
pubmed: 30814349
Clin Chem. 2001 Mar;47(3):426-30
pubmed: 11238292
Soc Sci Med. 2013 Sep;92:53-60
pubmed: 23849279
Curr Opin Lipidol. 2017 Feb;28(1):52-59
pubmed: 27906712
Lipids Health Dis. 2005 May 09;4:10
pubmed: 15882457
Diabetes Care. 2004 Jun;27(6):1276-80
pubmed: 15161775
Neuron. 2019 Mar 6;101(5):820-838
pubmed: 30844401
Future Lipidol. 2008 Oct;3(5):505-530
pubmed: 19649144
Philos Trans R Soc Lond B Biol Sci. 2020 Nov 9;375(1811):20190610
pubmed: 32951553
Nat Rev Immunol. 2015 Feb;15(2):104-16
pubmed: 25614320
FASEB J. 2017 Apr;31(4):1508-1515
pubmed: 28031319
Liver Int. 2016 Sep;36(9):1267-74
pubmed: 26880346
Chest. 2005 Feb;127(2):643-51
pubmed: 15706008
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):267-278
pubmed: 31694394
Am J Hum Biol. 2007 May-Jun;19(3):376-98
pubmed: 17421012
Ann Clin Transl Neurol. 2018 Sep 17;5(10):1229-1240
pubmed: 30349858
Ann Hum Genet. 2012 Jul;76(4):283-95
pubmed: 22681517
Elife. 2021 Sep 29;10:
pubmed: 34586066
EBioMedicine. 2020 Sep;59:102954
pubmed: 32818802
Nutrients. 2018 Jun 13;10(6):
pubmed: 29899295
Ageing Res Rev. 2017 Aug;37:146-161
pubmed: 28647612
PLoS One. 2017 Jul 6;12(7):e0179497
pubmed: 28683096
J Biol Rhythms. 2015 Aug;30(4):277-90
pubmed: 25900041
J Lipid Res. 2017 Oct;58(10):2051-2060
pubmed: 28830907
Aging Cell. 2019 Feb;18(1):e12869
pubmed: 30462377
Am J Phys Anthropol. 2010 Sep;143(1):100-11
pubmed: 20734437
Ann Hum Biol. 2006 May-Jun;33(3):279-308
pubmed: 17092867
Front Immunol. 2018 Apr 04;9:664
pubmed: 29670630
BMC Med. 2019 Mar 20;17(1):64
pubmed: 30890171
Sci Adv. 2020 Oct 28;6(44):
pubmed: 33115745
J Allergy Clin Immunol. 2014 Jul;134(1):127-34
pubmed: 24655576
Evol Hum Behav. 2020 Sep;41(5):330-340
pubmed: 33100820
Ann N Y Acad Sci. 2000 Jun;908:244-54
pubmed: 10911963
Biodemography Soc Biol. 2011;57(1):33-52
pubmed: 21845926
J Allergy Clin Immunol. 2018 Oct;142(4):1346-1349.e9
pubmed: 29928926
Q Rev Biol. 2019 Dec;94(4):333-394
pubmed: 32269391
Am J Hum Genet. 2000 Oct;67(4):881-900
pubmed: 10986041
JAMA Netw Open. 2018 Oct 5;1(6):e183597
pubmed: 30646251
Am J Hum Biol. 2020 Jan;32(1):e23356
pubmed: 31821682
Science. 2016 Nov 25;354(6315):999-1003
pubmed: 27885005
Evol Anthropol. 2017 Apr;26(2):54-73
pubmed: 28429567
Clin Biochem. 2007 Jun;40(9-10):575-84
pubmed: 17467679
J Lipid Res. 2002 Nov;43(11):1881-9
pubmed: 12401887

Auteurs

Angela R Garcia (AR)

Center for Evolution and Medicine, Arizona State University, Tempe, United States.
Department of Anthropology, Emory University, Atlanta, United States.

Caleb Finch (C)

Leonard Davis School of Gerontology, Dornsife College, University of Southern California, Los Angeles, Los Angeles, United States.

Margaret Gatz (M)

Center for Economic and Social Research, University of Southern California, Los Angeles, Los Angeles, United States.

Thomas Kraft (T)

Department of Anthropology, University of California, Santa Barbara, Santa Barbara, United States.

Daniel Eid Rodriguez (D)

Department of Medicine, Universidad de San Simón, Cochabamba, Bolivia.

Daniel Cummings (D)

Institute for Economics and Society, Chapman University, Orange, United States.

Mia Charifson (M)

Vilcek Institute of Graduate Biomedical Sciences, New York University, New York, United States.

Kenneth Buetow (K)

Center for Evolution and Medicine, Arizona State University, Tempe, United States.
School of Life Sciences, Arizona State University, Tempe, United States.

Bret A Beheim (BA)

Department of Human Behavior, Ecology and Culture, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Hooman Allayee (H)

Department of Preventive Medicine and Biochemistry & Molecular Medicine, Keck School of Medicine, University of Southern California, Irvine, Irvine, United States.
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Irvine, Irvine, United States.

Gregory S Thomas (GS)

Long Beach Memorial, Long Beach and University of California Irvine, Irvine, United States.

Jonathan Stieglitz (J)

Institute for Advanced Study in Toulouse, Universite Toulouse, Toulouse, France.

Michael D Gurven (MD)

Department of Anthropology, University of California, Santa Barbara, Santa Barbara, United States.

Hillard Kaplan (H)

Institute for Economics and Society, Chapman University, Orange, United States.

Benjamin C Trumble (BC)

School of Human Evolution and Social Change, Arizona State University, Tempe, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH